- Home
- IFRX vs NSTS Comparison
IFRX vs NSTS Comparison
Compare IFRX & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- NSTS
- Stock Information
- Founded
- IFRX 2007
- NSTS 1921
- Country
- IFRX Germany
- NSTS United States
- Employees
- IFRX N/A
- NSTS N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- NSTS Savings Institutions
- Sector
- IFRX Health Care
- NSTS Finance
- Exchange
- IFRX Nasdaq
- NSTS Nasdaq
- Market Cap
- IFRX 53.5M
- NSTS 63.0M
- IPO Year
- IFRX 2017
- NSTS N/A
- Fundamental
- Price
- IFRX $1.43
- NSTS $11.34
- Analyst Decision
- IFRX Strong Buy
- NSTS
- Analyst Count
- IFRX 5
- NSTS 0
- Target Price
- IFRX $7.40
- NSTS N/A
- AVG Volume (30 Days)
- IFRX 492.5K
- NSTS 5.5K
- Earning Date
- IFRX 11-07-2025
- NSTS 11-12-2025
- Dividend Yield
- IFRX N/A
- NSTS N/A
- EPS Growth
- IFRX N/A
- NSTS N/A
- EPS
- IFRX N/A
- NSTS N/A
- Revenue
- IFRX $191,224.00
- NSTS $9,435,000.00
- Revenue This Year
- IFRX N/A
- NSTS N/A
- Revenue Next Year
- IFRX $1,216.24
- NSTS N/A
- P/E Ratio
- IFRX N/A
- NSTS N/A
- Revenue Growth
- IFRX 54.36
- NSTS 69.39
- 52 Week Low
- IFRX $0.71
- NSTS $10.13
- 52 Week High
- IFRX $2.82
- NSTS $13.32
- Technical
- Relative Strength Index (RSI)
- IFRX 55.06
- NSTS 32.54
- Support Level
- IFRX $1.29
- NSTS $11.31
- Resistance Level
- IFRX $1.44
- NSTS $11.65
- Average True Range (ATR)
- IFRX 0.14
- NSTS 0.18
- MACD
- IFRX -0.00
- NSTS -0.03
- Stochastic Oscillator
- IFRX 48.84
- NSTS 3.62
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.